BioWorld - Tuesday, December 23, 2025
» Big pharma taps fast Asia innovation in search of next Keytruda
Big pharma taps fast Asia innovation in search of next Keytruda
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab), Merck & Co. Inc.’s reigning blockbuster cancer drug.
HIV research is close to a cure but far from ending the pandemic
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...